Faaborg Pharma Overview
- Founded
-
2001

- Status
-
Private
- Employees
-
26

- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Faaborg Pharma General Information
Description
Producer of skincare products intended to provide an efficient way to tackle dry and irritated skin. The company's products utilize ingredients like salicylic acid and hyaluronic acid with minimum additives and no fragrances to offer a range of facial care products that prevents and reduces pigmentation, the first signs of age like wrinkles and fine lines, enabling consumers to treat plain dehydration to atopic eczema on the face, hands, and feet at a minimal cost.
Contact Information
Website
www.faaborgpharma.dk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Primary Office
- Markedspladsen 13A
- 5600 Faaborg
- Denmark
+45 38 00 00 00
Faaborg Pharma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Early Stage VC | Completed | Startup |
Faaborg Pharma Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Sten Nielsen | Founder, Owner & Co-Chief Executive Officer | ||
Frank Vibæk | Co-Chief Executive Officer |
Faaborg Pharma Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Birk Andersen | Self | Board Member | 000 0000 |
Claus Wædeled | Faaborg Pharma | Chairman | 000 0000 |
Jan Knudsen | Self | Board Member | 000 0000 |
Faaborg Pharma Signals
Faaborg Pharma Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Welfare Tech Invest | Venture Capital | Minority | 000 0000 | 000000 0 |